Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00025168 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00025168 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer |
| Official title | Phase II Trial Of Induction Gemcitabine/CPT-11 Followed By Twice-Weekly Infusion Gemcitabine And Concurrent External Beam Radiation For The Treatment Of Locally Advanced Pancreatic Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | gemcitabine hydrochloride, irinotecan hydrochloride, radiation therapy |
| Enrollment | 20 |
| Start date | Nov 1, 2001 |
| Primary completion | Aug 29, 2003 |
| Completion | Aug 29, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: